Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Antimicrobial stewardship of β-lactams in intensive care units.

Cotta MO, Roberts JA, Tabah A, Lipman J, Vogelaers D, Blot S.

Expert Rev Anti Infect Ther. 2014 May;12(5):581-95. doi: 10.1586/14787210.2014.902308. Epub 2014 Mar 22. Review.

PMID:
24655303
2.

Impact of CLSI Breakpoint Changes on Microbiology Laboratories and Antimicrobial Stewardship Programs.

Heil EL, Johnson JK.

J Clin Microbiol. 2016 Apr;54(4):840-4. doi: 10.1128/JCM.02424-15. Epub 2016 Jan 20.

4.

Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.

MacGowan A.

Clin Microbiol Infect. 2008 Jan;14 Suppl 1:166-8. Review. Erratum in: Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4.

5.
6.
7.

Prevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physicians.

Kallen AJ, Beekmann SE, Limbago B, Lentnek AL, Polgreen PM, Patel J, Srinivasan A.

Diagn Microbiol Infect Dis. 2011 Nov;71(3):316-9. doi: 10.1016/j.diagmicrobio.2011.07.013. Epub 2011 Sep 6.

PMID:
21899980
8.

Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship.

George JM, Towne TG, Rodvold KA.

Pharmacotherapy. 2012 Aug;32(8):707-21. doi: 10.1002/j.1875-9114.2012.01157.x. Review.

PMID:
23307519
9.

beta-Lactams without a suicide inhibitor.

Giamarellou H.

Clin Microbiol Infect. 2008 Jan;14 Suppl 1:194-7. Review. Erratum in: Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4.

10.

De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients.

Shime N, Satake S, Fujita N.

Infection. 2011 Aug;39(4):319-25. doi: 10.1007/s15010-011-0116-6. Epub 2011 Apr 21.

PMID:
21509424
11.

[New beta-lactamases in enterobacteriaceae. The Danish Society of Clinical Microbiology].

Hansen DS.

Ugeskr Laeger. 2006 Mar 20;168(12):1228. Danish. No abstract available.

PMID:
16571319
12.

Emergence and risk factors of β-lactamase-mediated resistance to oxyimino-β-lactams in Enterobacteriaceae isolates.

Manageiro V, Ferreira E, Jones-Dias D, Louro D, Pinto M, Diogo J, Caniça M.

Diagn Microbiol Infect Dis. 2012 Mar;72(3):272-7. doi: 10.1016/j.diagmicrobio.2011.11.009. Epub 2011 Dec 29.

PMID:
22209509
13.

Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.

Harada S, Ishii Y, Yamaguchi K.

Korean J Lab Med. 2008 Dec;28(6):401-12. doi: 10.3343/kjlm.2008.28.6.401. Review.

14.
15.

Extended-spectrum beta-lactamase-producing organisms.

Falagas ME, Karageorgopoulos DE.

J Hosp Infect. 2009 Dec;73(4):345-54. doi: 10.1016/j.jhin.2009.02.021. Epub 2009 Jul 10. Review.

PMID:
19596491
16.

[Enterobacteriaceae and beta-lactams : wild susceptibility patterns].

Philippon A, Arlet G.

Pathol Biol (Paris). 2012 Apr;60(2):112-26. doi: 10.1016/j.patbio.2011.12.002. Epub 2012 Jan 26. Review. French.

PMID:
22280847
17.

Novel plasmid-mediated beta-lactamases in enterobacteriaceae: emerging problems for new beta-lactam antibiotics.

Thomson KS, Prevan AM, Sanders CC.

Curr Clin Top Infect Dis. 1996;16:151-63. Review. No abstract available.

PMID:
8714252
18.

Risk of resistant infections with Enterobacteriaceae in hospitalized neonates.

Singh N, Patel KM, Léger MM, Short B, Sprague BM, Kalu N, Campos JM.

Pediatr Infect Dis J. 2002 Nov;21(11):1029-33.

PMID:
12442024
19.

In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents.

Hsu MS, Liao CH, Liu CY, Yang CJ, Huang YT, Hsueh PR.

Int J Antimicrob Agents. 2011 Mar;37(3):276-8. doi: 10.1016/j.ijantimicag.2010.12.003. Epub 2011 Jan 26. No abstract available.

PMID:
21269811
20.

Extended-spectrum beta-lactamases: how big is the problem?

Rahal JJ.

Clin Microbiol Infect. 2000 Aug;6 Suppl 2:2-6. Review. No abstract available.

Supplemental Content

Support Center